Investment
Features
FeesSafety
Academy
More
Pluang+

ONWARD Medical appoints Fouad Azzam to its Board to support growth in spinal cord stimulation therapies.

Market News
21 Oct 2026
GlobeNewsWire
View Source
Bullish
ONWARD Medical appoints Fouad Azzam to its Board to support growth in spinal cord stimulation therapies.

ONWARD Medical has appointed Fouad Azzam, a Partner at EQT Life Sciences with extensive experience in medical technology investments, as a non-executive board member. This move aims to leverage his expertise to scale ONWARD's business and advance its innovative spinal cord stimulation therapies, including the ARC-EX® System and investigational ARC-IM® device. The company focuses on restoring movement and independence for people with spinal cord injuries and is developing cutting-edge implantable technologies paired with brain-computer interfaces. Azzam's addition is expected to strengthen ONWARD's strategic growth and innovation efforts.

ONWARD Medical's board appointment news is provided here with Health sector market data for context. For readers following Health stocks, 133 of 150 priced US stocks rose while 17 fell. Notable movers include DFTX at USD 35.19 (+6.73%), MRNA at USD 242.00 (+6.66%, 40% Sell / 60% Buy, typical hold 59 Days), and DVA at USD 174.65 (-6.60%, 24% Sell / 76% Buy, typical hold 115 Days) as of Oct 21, 2026 12:11 WIB.

More News

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

First patient treated in clinical trial of IBA's innovative ConformalFLASH® proton therapy for head and neck cancer.

IBA has treated the first patient in the C-FLASH-01 clinical trial, the first human study testing ConformalFLASH® proton therapy. This trial, conducted at Penn Medicine with FDA approval, explores the feasibility of using ultra-high dose rate proton ...

Market News
Bullish
45 minutes ago
WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey lists on Nasdaq, aims to build secure AI and satellite platform for the Intelligence Age

WISeQey Corp. completed its redomiciliation and began trading on Nasdaq and the SIX Swiss Exchange, marking a new phase focused on integrating its quantum cybersecurity, digital identity, and space IoT technologies. Its subsidiary WISeSat.Space also ...

Market News
Bullish
45 minutes ago
IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA treats first patient in clinical trial for innovative ConformalFLASH® proton therapy

IBA has treated the first patient in the C-FLASH-01 clinical trial, testing its ConformalFLASH® proton therapy for head and neck cancer re-irradiation. This trial, led by Penn Medicine and approved by the FDA, explores ultra-high dose rate proton the...

Market News
Bullish
45 minutes ago
Sika to acquire Resonac's adhesives business, boosting growth in Asian automotive markets.

Sika to acquire Resonac's adhesives business, boosting growth in Asian automotive markets.

Sika AG has agreed to acquire the adhesives business of Japan's Resonac Corporation, which serves automotive customers across Asia. This acquisition will expand Sika's access to key Japanese automotive OEM suppliers and broaden its product offerings,...

Company Fundamentals
Bullish
45 minutes ago
Hudbay and Mitsubishi approve Copper World project, aiming for U.S. copper mine production by 2029

Hudbay and Mitsubishi approve Copper World project, aiming for U.S. copper mine production by 2029

Hudbay and Mitsubishi have approved the construction of the Copper World project, a major new copper mine in the U.S. This project is significant as it advances the development of a key resource mine, with production expected to begin in 2029. The ap...

Market News
Bullish
45 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App